Prostate cancer: Cryotherapy

Urologic Clinics of North America

Volumn 30, Issue 4, 2003, Pages 725-736

  Shinohara, Katsuto ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANATOMY; BIOCHEMISTRY; BIOLOGY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SCREENING; CELL DEATH; CRYOSURGERY; CRYOTHERAPY; EQUIPMENT; FOLLOW UP; FREEZING; HISTOLOGY; HISTORY; HUMAN; IMPOTENCE; INCIDENCE; INCONTINENCE; LYMPH NODE DISSECTION; MORBIDITY; PAIN; PARESTHESIA; PATIENT SELECTION; PELVIS PAIN SYNDROME; PENIS; PENIS DISEASE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECTUM; REVIEW; RISK BENEFIT ANALYSIS; SALVAGE THERAPY; TECHNIQUE; THAWING; TISSUE NECROSIS; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; URETHRA FISTULA; URETHRA STRICTURE;

EID: 0344011548     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(03)00065-X     Document Type: Review

References (52)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Fowler FJ Jr., Barry MJ, Lu-Yao G, et al. Patient reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990. Urology 1993;42:622-9.
3. Kabalin JN, Hodge KK, McNeal JE, et al. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 1989;142:326-31.
4. Arnott J. On the treatment of cancer by the regulated application of an anesthetic temperature. London: J Churchill; 1851.
5. Cooper IS, Hirose T. Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med 1966;274(1):15-8.
6. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966;3:372-8.
7. Soanes WA, Gonder MJ. Use of cryosurgery in prostatic cancer. J Urol 1968;99:793-7.
8. Megalli MR, Gursel EO, Veenema RJ. Closed perineal cryosurgery in prostatic cancer. New probe and technique. Urology 1974;4:220-2.
9. Onik G, Cobb C, Cohen J, et al. US characteristics of frozen prostate. Radiology 1988;168:629-31.
10. Saliken J, Donnelly B, Rewcastle J. The evolution and state of modern technology for prostate cryosurgery. Urology 2002;62(2 Supp 1):26-33.
11. de la Taille A, Benson MC, Bagiella E, et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int 2000;85(3): 281-6.
12. Zisman A, Pantuck AJ, Cohen JK, et al. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology 2001;58(6):988-93.
13. O'Leary MP, Baum NH, Blizzard R, et al. 2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. J Urol 2002;168(2):649-52.
14. Mazur P. Cryobiology: the freezing of biological systems. Science 1970;168:939-49.
15. Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996;48:441-7.
16. Gage AA. Experimental cryogenic injury of the palate: observations pertinent to cryosurgical destruction of tumors. Cryobiology 1978;15:415-25.
17. Larson TR, Rrobertson DW, Corica A, Bostwick DG. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology 2000;55:547-52.
18. Pisters LL, von Eschenbach AC, Scott SM, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997;157(3):921-5.
19. Brenner PC, Russo P, Wood DP, Morse MJ, Donat SM, Fair WR. Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation. Br J Urol 1995;75(1): 44-7.
20. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995;153(1):104-10.
21. Reckwitz T, Potter SR, Partin AW. Prediction of locoregional extension and metastatic disease in prostate cancer: a review. World J Urol 2000;18(3): 165-72.
22. Oesterling JE. Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications. Urol Clin North Am 1993;20:705-11.
23. Chin JL, Pautler SE, Mouraviev V, et al. Results of salvage cryoublation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001;165(6 Pt 1):1937-41 [discussion: 1941-2].
24. Gleason DF, Mellinger GT, Group VACUR. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 1974;111:58-64.
25. Koppie TM, Shinohara K, Grossfeld GD, et al. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol 1999;162(2):427-32.
26. Long JP, Bahn D, Lee F, et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001;57(3):518-23.
27. Perrotti M, Gentle DL, Barada JH, Wilbur HJ, Kaufman RP. Mini-laparotomy pelvic lymph node dissection minimizes morbidity, hospitalization and cost of pelvic lymph node dissection. J Urol 1996;155:986-8.
28. de la Taille A, Hayek O, Benson MC, et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 2000;55(1):79-84.
29. Wieder J, Schmidt JD, Casola G, et al. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol 1995;154(2 Pt 1):435-41.
30. Shinohara K, Rhee B, Presti JC Jr., et al. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol 1997;158(6):2206-9 [discussion: 2209-10].
31. Aboseif S, Shinohara K, Borirakchanyavat S, et al. The effect of cryosurgical ablation of the prostate on erectile function. Br J Urol 1997;80(6):918-22.
32. El-Sakka AI, Hassan MU, Selph C, et al. Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia. J Urol 1998;160(6 Pt 1):2245-52.
33. Bahn DK, Lee F, Badalament R, et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002;60(2 Suppl 1):3-11.
34. Long JP, Fallick ML, LaRock DR, et al. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 1998;159(2):477-84.
35. Robinson JW, Donnelly BJ, Saliken JC, et al. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 2002;60(2 Suppl 1):12-8.
36. Cohen JK, Miller RJ, Rooker GM, et al. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology 1996;47(3):395-401.
37. Cox RL, Crawford ED. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology 1995;45(6): 932-5.
38. Ghafar MA, Johnson CW, De La Taille A, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001;166(4):1333-7 [discussion: 1337-8].
39. Bales GT, Williams MJ, Sinner M, et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology 1995;46(5):676-80.
40. Wong WS, Chinn DO, Chinn M, et al. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 1997;79(5):963-74.
41. Cespedes RD, Pisters LL, von Eschenbach AC, et al. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol 1997;157(1):237-40.
42. Shinohara K, Connolly JA, Presti JC Jr., et al. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol 1996;156(1):115-20 [discussion 120-1].
43. Coogan CL, McKiel CF. Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol 1995;154(5):1813-7.
44. Bahn DK, Lee F, Solomon MH, et al. Prostate cancer: US-guided percutaneous cryoablation. Work in progress. Radiology 1995;194(2):551-6.
45. Connolly JA, Shinohara K, Presti JC Jr, et al. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996;23(4):623-31.
46. Lee F, Bahn DK, Badalament RA, et al. Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes. Urology 1999;54(1):135-40.
47. Ellis DS. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 2002;60(2 Suppl 1):34-9.
48. Gould RS. Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery. J Urol 1999;162(5): 1653-7.
49. Rukstalis DB, Goldknopf JL, Crowley EM, et al. Prostate cryoablation: a scientific rationale for future modifications. Urology 2002;60(2 Suppl 1): 19-25.
50. Onik G, Narayan P, Vaughan D, et al. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002;60(1):109-14.
51. Clarke DM, Baust JM, Van Buskirk RG, et al. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology 2001;42(4):274-85.
52. Pham L, Dahiya R, Rubinsky B. An in vivo study of antifeeze protein adjuvant cryosurgery. Cryobiology 1999;38:169-75.